Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126481322 | 12648132 | 2 | F | 20160811 | 20160812 | 20160825 | EXP | GB-TEVA-682440ACC | TEVA | 0.00 | F | Y | 0.00000 | 20160825 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126481322 | 12648132 | 1 | PS | ANASTROZOLE. | ANASTROZOLE | 1 | Y | 78058 | |||||||||||
| 126481322 | 12648132 | 2 | SS | ANASTROZOLE. | ANASTROZOLE | 1 | Y | 78058 | |||||||||||
| 126481322 | 12648132 | 3 | SS | ARIMIDEX | ANASTROZOLE | 1 | Y | 0 | |||||||||||
| 126481322 | 12648132 | 4 | SS | Anastrozole (Accord Healthcare) | ANASTROZOLE | 1 | Y | 0 | |||||||||||
| 126481322 | 12648132 | 5 | SS | ANASTROZOLE (Hungary) | ANASTROZOLE | 1 | Y | 0 | |||||||||||
| 126481322 | 12648132 | 6 | SS | ANASTROZOLE (cyprus) | ANASTROZOLE | 1 | Y | 0 | |||||||||||
| 126481322 | 12648132 | 7 | SS | ANASTROZOLE (Estonia) | ANASTROZOLE | 1 | Y | 0 | |||||||||||
| 126481322 | 12648132 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | FEW MONTHS | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126481322 | 12648132 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126481322 | 12648132 | Abasia | |
| 126481322 | 12648132 | Adverse drug reaction | |
| 126481322 | 12648132 | Anxiety | |
| 126481322 | 12648132 | Confusional state | |
| 126481322 | 12648132 | Disability | |
| 126481322 | 12648132 | Discomfort | |
| 126481322 | 12648132 | Drug hypersensitivity | |
| 126481322 | 12648132 | Drug intolerance | |
| 126481322 | 12648132 | Drug level increased | |
| 126481322 | 12648132 | Emotional distress | |
| 126481322 | 12648132 | Fear | |
| 126481322 | 12648132 | Hernia | |
| 126481322 | 12648132 | Lip swelling | |
| 126481322 | 12648132 | Menopausal symptoms | |
| 126481322 | 12648132 | Mental disorder | |
| 126481322 | 12648132 | Movement disorder | |
| 126481322 | 12648132 | Muscle disorder | |
| 126481322 | 12648132 | Muscle tightness | |
| 126481322 | 12648132 | Overdose | |
| 126481322 | 12648132 | Paraesthesia oral | |
| 126481322 | 12648132 | Product substitution issue | |
| 126481322 | 12648132 | Speech disorder | |
| 126481322 | 12648132 | Stress | |
| 126481322 | 12648132 | Swollen tongue | |
| 126481322 | 12648132 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126481322 | 12648132 | 1 | 2012 | 2013 | 0 | |
| 126481322 | 12648132 | 2 | 201305 | 201402 | 0 | |
| 126481322 | 12648132 | 4 | 201305 | 201305 | 0 | |
| 126481322 | 12648132 | 8 | 2012 | 2013 | 0 |